Cargando…
Hypoglycemia possibly caused by CYP2C9-mediated drug interaction in combination with bucolome: a case report
BACKGROUND: Bucolome is a non-steroidal anti-inflammatory drug and uricosuric agent, currently used only in Japan. It is known to induce drug interactions by inhibiting cytochrome P450 (CYP) 2C9. It is often used to enhance the anticoagulant effect of warfarin by utilizing its drug interactions. The...
Autores principales: | Tateishi, Hiroki, Miyazu, Daisuke, Kurinami, Miho, Ieiri, Ichiro, Hirakawa, Masaaki, Watanabe, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564963/ https://www.ncbi.nlm.nih.gov/pubmed/34727989 http://dx.doi.org/10.1186/s40780-021-00221-y |
Ejemplares similares
-
Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report
por: Kato, Takashi, et al.
Publicado: (2023) -
DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report
por: Miyazu, Daisuke, et al.
Publicado: (2016) -
Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy
por: Lakhan, Ram, et al.
Publicado: (2011) -
Restoration of the Hypothalamic-pituitary-adrenal Response to Hypoglycemia in Type 2 Diabetes by Avoiding Chronic Hypoglycemia
por: Tsuda, Shin-ichi, et al.
Publicado: (2016) -
Does hypoglycemia cause cardiovascular events?
por: Chopra, Sandeep, et al.
Publicado: (2012)